FDA
- Status: approved
🇺🇸 0.1% and 0.4% perineural ropivicaine in United States
0.1% and 0.4% perineural ropivicaine (0.1% and 0.4% perineural ropivicaine) regulatory status in United States.
Marketing authorisation
0.1% and 0.4% perineural ropivicaine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is 0.1% and 0.4% perineural ropivicaine approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for 0.1% and 0.4% perineural ropivicaine in United States?
University of California, San Diego is the originator. The local marketing authorisation holder may differ — check the official source linked above.